These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 17532620

  • 1. A nested case-control study of stomach cancer and serum insulin-like growth factor (IGF)-1, IGF-2 and IGF-binding protein (IGFBP)-3.
    Pham TM, Fujino Y, Kikuchi S, Tamakoshi A, Yatsuya H, Matsuda S, Yoshimura T, JACC Study Group.
    Eur J Cancer; 2007 Jul; 43(10):1611-6. PubMed ID: 17532620
    [Abstract] [Full Text] [Related]

  • 2. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 3. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 4. Relationship between serum levels of insulin-like growth factors and subsequent risk of cancer mortality: findings from a nested case-control study within the Japan Collaborative Cohort Study.
    Pham TM, Fujino Y, Nakachi K, Suzuki K, Ito Y, Watanabe Y, Inaba Y, Tajima K, Tamakoshi A, Yoshimura T, JACC Study Group.
    Cancer Epidemiol; 2010 Jun 15; 34(3):279-84. PubMed ID: 20427254
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun 15; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.
    Serrano ML, Romero A, Cendales R, Sánchez-Gómez M, Bravo MM.
    Biomedica; 2006 Jun 15; 26(2):258-68. PubMed ID: 16925098
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr 15; 13(4):607-12. PubMed ID: 15066926
    [Abstract] [Full Text] [Related]

  • 8. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May 15; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 15; 14(1):48-52. PubMed ID: 15668475
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H, Flyvbjerg A, Mellemkjaer L, Tjønneland A, Christensen J, Sørensen HT, Overvad K.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov 15; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [Abstract] [Full Text] [Related]

  • 12. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer; 2005 Jan 01; 103(1):76-84. PubMed ID: 15540247
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May 01; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.